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LETTER TO THE EDITOR
MOBILE PHONES, NON-IONIZING RADIOFREQUENCY FIELDS AND BRAIN
CANCER: IS THERE AN ADAPTIVE RESPONSE?
Vijayalaxmi   Department of Radiology, University of Texas Health Science
Center
Thomas J. Prihoda   Department of Pathology, University of Texas Health
Science Center
  There is widespread concern among the general public regarding the ever increasing
use of mobile phones. The concern is mainly because the antenna which transmits non-
ionizing radiofrequency fields is held close to the head during use and thus might cause
brain cancer. By far, the largest epidemiological study was conducted by the INTER-
PHONE study group and the results were published in 2011. The author’s conclusions
were (i) no increased risk of meningioma and glioma in mobile phone users and (ii) there
were suggestions of an increased risk for glioma at the highest exposure levels but, bias
and error prevented a causal interpretation. We have carefully examined all of the odd
ratios presented in the INTERPHONE study publication: our results showed 24.3%
decreased and 0.7% increased risk for meningioma and 22.1% decreased and 6.6%
increased risk for glioma. Hence, we hypothesize that the overwhelming evidence for the
decreased risk for both diseases may be due to the induction of ‘adaptive response’ which
is well-documented in scientific literature
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Non-ionizing radiofrequency fields (RF) are ubiquitous in our envi-
ronment, especially after the introduction of wireless communications
devices which deliver voice, data and images. The widespread use of
mobile phones has led to increased concern in the general public regard-
ing potential adverse health effects, especially brain cancer since the
antenna which transmit RF is held close to the head during use. During
the last several decades, researchers have been examining the extent of
genetic damage in human and animal cells exposed in vivo and in vitro to
RF since significant increase in such damage in somatic cells can lead to
the development of cancer and/or cell death while such damage in germ
cells can be transmitted to subsequent generations. The conclusions from
peer-reviewed scientific publications and reviews, expert scientific adviso-
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ry committees in several countries and international organizations were
similar: the currently available data did not provide sufficient evidence
that RF exposure per se is genotoxic (reviewed in Verschaeve et al. 2010;
Verchaeve 2012). The issue related to RF emitted from mobile phone use
and the development of brain cancer was examined in several epidemio-
logical investigations. The data were controversial: some suggested
increased incidence of brain and other types of cancers while the others
did not (reviewed in Repacholi et al. 2012).
By far, the largest investigation was conducted by the INTERPHONE
study group using a common protocol in 13 countries with 16 study cen-
ters. It was interview-based case-control study with its main analyses involv-
ing 2409 meningioma and 2708 glioma cases, i.e., individuals using
mobile phone regularly (without hands-free device, cumulative call time
of <5 to >1640 hours and cumulative number of calls of <1.5x100 to
<270x100) and, 2662 and 2972 controls matched for age, gender and
area of residence, respectively. The detailed odd ratios (ORs) and 95%
confidence limits (CI) for meningioma and glioma were presented in
Tables 2-6 in the publication (The INTERPHONE study group 2010). We
have carefully examined all ORs (<1.0 for decreased and >1.0 for
increased risk) and CIs (<1.0 for decreased and >1.0 for increased risk)
presented in each of these tables and our results for meningioma and
glioma separately as well as together for both diseases were summarized
in Table 1. There was a consistent and inter-country replication pattern
of reduced risk for both meningioma and glioma in mobile phone users.
(1) For meningioma, there were a total of 33 ORs which were <1.0 
(CI <1.0) and only 1 OR which was >1.0 (CI >1.0) in a total of 136 ORs:
the highest OR of 4.80 (1.49-15.4 CI) for >1640 hours of cumulative call
time was based on small number of cases (Table 3 in the INTERPHONE
Vijayalaxmi and T.J. Prihoda
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TABLE 1. Summary of odd ratios (ORs) and 95% confidence limits (CI) for meningioma and
glioma presented in Tables 2-6 by the INTERPHONE STUDY group (2010)*. 
Meningioma Glioma Meningioma + glioma
↓Risk ↑Risk Total ↓Risk ↑Risk Total ↓Risk ↑Risk Total
p<0.05 p<0-05 ORs p<0.05 p<0-05 ORs p<0.05 p<0-05 ORs
Table 2 9 0 25 11 1 25 20 1 50
Table 3 3 1 15 4 1 15 7 2 30
Table 4 13 0 45 5 1 45 18 1 90
Table 5 8 0 30 10 1 30 18 1 60
Table 6 0 0 21 0 5 21 0 5 42
Total ORs 33 1 136 30 9 136 63 10 272
% ORs 24.3 0.7 22.1 6.6 23.2 3.7
*International Journal of Epidemiology. 39, 675-694, 2010.
↑Risk: Odd ratios >1.0 with 95% confidence limits >1.0
↓Risk: Odd ratios <1.0 with 95% confidence limits <1.0
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study group 2010). Thus, the overall ORs indicated 24.3% reduced and
0.7% increased risk for meningioma. (2) For glioma, there were a total of
30 ORs which were <1.0 (CI <1.0) and 9 ORs which were >1.0 (CI >1.0)
in a total of 136 ORs: the highest OR of 3.77 (1.25-11.4 CI) reported for
>1640 hours of cumulative call time was based on small number of cases
(Table 3 in the INTERPHONE study group 2010). Thus, the overall ORs
indicated 22.1% reduced and 6.6% increased risk for glioma. As the
authors of the INTERPHONE study group pointed out (see below) the
6.6 % risk for glioma (p<0.05) may be due to ‘bias’ and ‘error’ in mobile
phone use reported by the participants in the interphone study (see
below). When the ORs and CIs for meningioma and glioma were consid-
ered together, there were 63 ORs which were <1.0 (CI <1.0) and 10 ORs
which were >1.0 (CI >1.0) among the total of 272 ORs. Thus, the overall
ORs indicated 23.2% decreased and 3.7% increased risk for brain cancer.
Nonetheless, the conclusions of the INTERPHONE study group
(2010): (a) there was no increased risk of meningioma and glioma with
the use of mobile phones and, (b) there were suggestions of an increased
risk for glioma at the highest exposure levels, but, bias and error pre-
vented a causal interpretation. Considering the null hypothesis of no
association between mobile phone use and brain cancer, the ORs of >1.0
and <1.0 would be expected. However, the observed consistent and repli-
cated pattern of reduced risk would have very small probability of occur-
ring just by chance (Saracci and Samet 2010). Our observations of 24.3%
‘reduced’ risk for meningioma and 22.1% ‘reduced’ risk for glioma
(overall 23.2% reduced risk) were more than that expected by chance
occurrence (p<0.05). In May 2011, the International Agency for Research
on Cancer had invited an expert working group of scientists to assess the
carcinogenicity of RF; the group reviewed all relevant peer-reviewed pub-
lications, considered the ‘limited’ evidence from human and long-term
carcinogenicity studies in experimental animals and, classified RF as a
possible carcinogen in group 2B (Baan et al. 2011). Such classification was
not supported, at least, by genotoxicity-based mechanism (Vijayalaxmi
and Prihoda 2012). Furthermore, the overall brain cancer indices among
the general population did not suggest an increasing trend after the
introduction of mobile phones (Roosli et al. 2007; Inskip et al. 2010; de
Vocht et al. 2011; Deltour et al. 2012). A more recent prospective study
also revealed significantly decreased risk for glioma in mobile phone
users (Benson et al. 2013).
In this context, it is relevant to discuss the phenomenon of adaptive
response (AR) which was originally described by Samson and Crains
(1977): cells which were exposed to a very low, nontoxic dose (adaptive
dose, AD) of a mutagen become resistant to the damage induced by sub-
sequent exposure to high dose (challenge dose, CD) of the same or sim-
ilar mutagens. Subsequent studies confirmed the induction of AR (espe-
Mobile phones and adaptive response
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cially, by low dose ionizing radiation) in several different organisms
including human cells and, some underlying mechanisms were investi-
gated and discussed (Dimova et al. 2008). The data in some studies also
suggested variability/heterogeneity in the induction of AR, i.e. cells from
some blood donors exhibited AR while others did not: the suggestion was
that such variability might be, at least in part, genetically determined
(Bosi and Olivieri 1989; Vijayalaxmi et al. 1995; Krishnaja and Sharma
2008). Several recent reports published in peer reviewed scientific jour-
nals indicated that non-ionizing RF exposure was capable of inducing AR:
(i) human blood lymphocytes exposed in vitro to RF (AD) and then treat-
ed with a high dose of a chemical mutagen or ionizing radiation (CD)
exhibited significantly decreased genetic damage (Sannino et al. 2009;
Sannino et al. 2011; Zeni et al. 2012; Sannino et al. 2013), (ii) continuous-
ly growing human tumor cells exposed to RF and then treated with a
chemotherapeutic drug showed significantly increased viability,
decreased apoptosis, and several other biological endpoints indicating
protective influence of RF exposure (Jin et al. 2012) and (iii) mice and
rats exposed (whole body) to RF and subsequently subjected to sub-lethal
and lethal doses of ionizing radiation showed significant survival advan-
tage, less severe hematopoietic tissue damage, decreased genetic damage
in blood and bone marrow cells, increased levels of colony stimulating
factor and interleukin-3 in the serum and increased expression of genes
related to cell cycle, etc. (Cao et al. 2010, 2011; Jiang et al. 2012, 2013;
Mortazavi et al. 2011, 2012, 2013; Haghani et al. 2013). Thus, the results
in these reports also provided some mechanistic evidence for RF-induced
AR and several others were proposed (Vijayalaxmi et al. 2014). In view of
the above observations, we hypothesize that RF-induced AR may play a
role in reducing carcinogenesis, at least, in some individuals. The hypoth-
esis may be far-fetched and perhaps unconvincing but, stimulating for fur-
ther investigation(s).
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